孕前苯二氮䓬类药物使用与异位妊娠风险
IPT加权后风险比为1.47(95%CI 1.32-1.63),焦虑症亚组RR为1.34(95%CI 1.18-1.53),失眠亚组RR为1.28(95%CI 0.99-1.68)。
要点
- 孕前90天内有苯二氮䓬类处方者异位妊娠风险增加约50%。
- 焦虑症诊断女性中该关联仍显著(RR 1.34),失眠诊断女性中不显著。
- 每万次妊娠中,暴露组多出80例异位妊娠。
核心结论
- 孕前填写苯二氮䓬类处方与异位妊娠风险升高相关。
研究设计与样本
- 使用未调整和IPT加权对数二项模型计算相对风险。
主要发现
- 1.06%的妊娠在孕前90天内填写至少两张苯二氮䓬类处方且总供应天数至少10天。
- IPT加权后异位妊娠风险比为1.47(95%CI 1.32-1.63)。
- 焦虑症亚组IPT加权RR为1.34(95%CI 1.18-1.53)。
- 失眠亚组IPT加权RR为1.28(95%CI 0.99-1.68)。
关键数值与推荐
- 暴露定义:孕前90天内填写至少两张苯二氮䓬类处方且总供应天数至少10天。
- 主要结局:通过诊断和操作代码识别异位妊娠。
临床怎么用
- 育龄女性使用苯二氮䓬类药物时应告知异位妊娠风险升高,以助医患共同决策。
局限性
- 依赖门诊处方数据识别孕前用药,可能高估或低估实际用药。
- 依赖医疗索赔代码识别妊娠及受孕日期,可能导致妊娠结局和孕周错分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are women who fill a benzodiazepine prescription before conception at increased risk of ectopic pregnancy? SUMMARY ANSWER: Risk of ectopic pregnancy is 50% higher among women who fill a benzodiazepine prescription before conception. WHAT IS KNOWN ALREADY: Benzodiazepine use in pregnancy increases the risk of miscarriage, adverse birth outcomes and adverse child development outcomes. STUDY DESIGN, SIZE, DURATION: Using data from US commercial insurance claims, we performed a cohort study of 1 691 366 pregnancies between 1 November 2008 and 30 September 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: We identified ectopic pregnancies using diagnosis and procedure codes and used unadjusted and inverse probability of treatment (IPT)-weighted log-binomial models to calculate relative risks (RR) of ectopic pregnancy for pregnant women who did and did not fill any prescriptions for benzodiazepines in the 90 days before conception. Two sub-groups of women with specific indications for benzodiazepine use were also examined-women who had a least one diagnosis for anxiety disorder and women who had at least one diagnosis of insomnia in the year before conception. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 1 691 366 pregnancies, 1.06% filled at least two benzodiazepine prescriptions totaling at least 10 days supply in the 90 days before conception. Among women with a benzodiazepine prescription, there was an excess of 80 ectopic pregnancies per 10 000 pregnancies, and their IPT-weighted risk of ectopic pregnancies was 1.47 (95% CI 1.32 to 1.63) times greater relative to women without benzodiazepine prescriptions before conception. The IPT-weighted RR between ectopic pregnancy and benzodiazepine use was 1.34 (95% CI 1.18 to 1.53) among women with anxiety disorder diagnoses and 1.28 (95% CI 0.99 to 1.68) among women with an insomnia diagnosis. LIMITATIONS, REASONS FOR CAUTION: We relied on outpatient prescription data to identify benzodiazepine use before conception, which could result in over- or under-estimation of actual benzodiazepine consumption. We relied on medical claim codes to identify pregnancies and conception date, which may result in misclassification of pregnancy outcomes and gestational length. WIDER IMPLICATIONS OF THE FINDINGS: This study found that women who have a benzodiazepine prescription before conception are at an increased risk of ectopic pregnancy. This information can help women, and their healthcare providers make more fully informed decisions about benzodiazepine use in their reproductive years. STUDY FUNDING/COMPETING INTEREST(S): Funding for this project was provided by a Banting Postdoctoral Fellowship and a Stanford Maternal and Child Health Research Institute Postdoctoral Award. Data access for this project was provided by the Stanford Center for Population Health Sciences Data Core. The PHS Data Core is supported by a National Institutes of Health National Center for Advancing Translational Science Clinical and Translational Science Award (UL1 TR001085) and internal Stanford funding. The authors have no competing interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wall-Wieler E, Robakis TK, Lyell DJ, et al. Benzodiazepine use before conception and risk of ectopic pregnancy. Hum Reprod. 2020. PMID: 32485732. doi:10.1093/humrep/deaa082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。